Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort descending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort descending Business Functional Area Date Posted
Procure to Pay Business Partner Management INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) France Finance Innovative Medicines Others May 17, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 17, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Oct 17, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Jun 26, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Oct 06, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Jun 20, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit & Finance Jul 17, 2024
县域主任/县域主管 Dazhou (Sichuan Province) China International Innovative Medicines Sales Jul 04, 2024
Senior District Manager Zhanjiang (Guangdong Province) China International Innovative Medicines Sales Jul 05, 2024
Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Communications & Public Affairs Jul 09, 2024
Senior Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Market Access Sep 03, 2024
RLT Formulation Project Leader Ivrea Italy International Innovative Medicines Research & Development Sep 03, 2024
RLT Analytical Product Project Leader (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Jul 11, 2024
RLT Analytical Expert (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Jul 11, 2024
RLT Drug Product Project Lead (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Jul 11, 2024
Disease Area Specialist Israel Israel International Innovative Medicines Sales Jul 15, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Jul 15, 2024
RLT HCS & Partnerships Head Shanghai (Shanghai) China International Innovative Medicines Marketing Sep 03, 2024
Solution & Service Design Manager London (The Westworks) United Kingdom International Innovative Medicines Market Access Aug 15, 2024
Director HSPD Asset Lead and Expert London (The Westworks) Switzerland International Innovative Medicines Marketing Sep 03, 2024
Key Account Manager, Haematology - South West Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Aug 21, 2024
(Sr.) Sales Executive-Solid Tumor Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Sales Aug 22, 2024
Portfolio Account Specialist (Immunology, VIC West) Victoria (VIC) Australia International Innovative Medicines Sales Sep 11, 2024
Public Affairs Manager Ankara Gimat Turkey International Innovative Medicines Communications & Public Affairs Sep 13, 2024
Sr.Territory Business Executive Madhya Pradesh India International Innovative Medicines Sales Oct 03, 2024
Job Posting Title Sales Representative (w/m/d), TA: Onkologie, Gebiet: Österreich West Vienna Austria International Innovative Medicines Sales Oct 07, 2024
Customer Service Specialist: Pharma Supply Chain Prague Czech Republic International Innovative Medicines Technical Operations Oct 07, 2024
Pricing Manager New South Wales (NSW) Australia International Innovative Medicines Market Access Jul 31, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Aug 06, 2024
Product Specialist Jingzhou (Hubei Province) China International Innovative Medicines Sales Aug 06, 2024
Sr. TA Strategy Lead (Renal Therapy Area) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Aug 07, 2024
PMO, Corporate Shanghai (Shanghai) China International Innovative Medicines BD&L & Strategic Planning Aug 08, 2024
PMO, CRM&IPA Shanghai (Shanghai) China International Innovative Medicines BD&L & Strategic Planning Aug 08, 2024
Medical Scientific Liaison İstanbul Kavacık Turkey International Innovative Medicines Research & Development Sep 26, 2024
县域主任(主管) Luoyang (Henan Province) China International Innovative Medicines Sales Sep 26, 2024
P&R Manager Seoul South Korea International Innovative Medicines Market Access Sep 27, 2024
Regional Business Manager Mumbai (Head Office) India International Innovative Medicines Sales Sep 27, 2024
Regional Business Manager Delhi (Office) India International Innovative Medicines Sales Sep 27, 2024
Medical Science Liaison (MSL), Czech Republic Prague Czech Republic International Innovative Medicines Research & Development Sep 27, 2024
Field Sales Leader, Oncology (Scotland, Northern Ireland & North East England) Field Force (Scotland) United Kingdom International Innovative Medicines Sales Sep 27, 2024
(高级)医药代表 /(资深)产品专员 Xian (Shanxi Province) China International Innovative Medicines Sales Sep 29, 2024
Medical Science Liaison, Immunology Chongqing (Chongqing Province) China International Innovative Medicines Research & Development Sep 30, 2024
Senior Market Access Manager New South Wales (NSW) Australia International Innovative Medicines Market Access Sep 30, 2024
Key Account Manager , Haematology - Yorkshire, East Midlands, Northamptonshire. Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Sep 03, 2024
ASCVD Brand Manager Seoul South Korea International Innovative Medicines Marketing Sep 03, 2024
Sr. Medical Science Liaison, ASCVD Seoul South Korea International Innovative Medicines Research & Development Sep 05, 2024
Senior Manager, Marketing- Cardiovascular Makati City Philippines International Innovative Medicines Marketing Sep 05, 2024
Senior MR Haikou (Hainan Province) China International Innovative Medicines Sales Sep 05, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only